ITC Bars Certain Photon-Counting CT Modules

On June 2, 2026, the U.S. International Trade Commission issued a final determination in a Section 337 investigation affecting Photon-counting CT image reconstruction modules, creating immediate trade and compliance implications for medical imaging component exporters, importers, OEM system manufacturers, and supply chain auditors because certain modules are now barred from export to the United States and from sale in the U.S. market.

What the ITC Final Determination Confirms

The confirmed event concerns the U.S. International Trade Commission final determination dated June 2, 2026, in Investigation No. 337-TA-1428.

According to the provided case summary, the ITC determined that Photon-counting CT dedicated image reconstruction modules from three Chinese companies infringed U.S. patent US11229345B2. The determination took effect on the same date.

The measure prohibits the relevant modules from being exported to the United States and from being sold in the U.S. market. The final determination does not extend to complete CT systems. However, importers are required to provide a compliance declaration on the source of the modules, which affects supply chain audits conducted by OEM system manufacturers.

Compliance Effects Across the Medical Imaging Supply Chain

Direct trade companies facing immediate shipment controls

Direct trade companies are affected because the restriction applies to the relevant Photon-counting CT image reconstruction modules entering or being sold in the U.S. market. The impact is most visible in export screening, order acceptance, customs documentation, sales contract review, and post-shipment risk control.

These companies may need to pay closer attention to whether traded modules fall within the scope described in the final determination, whether module source declarations can be supported, and whether existing commercial arrangements require adjustment before shipment or resale.

Component and materials procurement teams under closer source review

Procurement organizations are affected because the importer declaration requirement shifts attention upstream to the source and identity of the relevant image reconstruction modules. Even though the determination does not cover complete systems, the compliance status of a module can influence whether an OEM can pass supply chain review for U.S.-bound products.

The main business links affected include supplier onboarding, bill-of-materials verification, purchase order terms, technical file collection, and documentation of component origin. Procurement teams may need to monitor whether suppliers can provide traceable module information and whether substitute sourcing plans are required for U.S.-related projects.

Manufacturing and integration businesses reviewing system configurations

Processing, assembly, and manufacturing companies may be affected when they integrate Photon-counting CT image reconstruction modules into larger systems or subassemblies. Although complete systems are not directly covered by the final determination, OEMs may still require evidence that restricted modules are not used in products intended for the U.S. market.

The affected operational areas may include production configuration control, engineering change management, incoming inspection, module serialization, technical documentation, and final delivery review. Manufacturers should watch whether customers update specifications, compliance clauses, or acceptance requirements connected to module sourcing.

Supply chain service providers supporting audit readiness

Supply chain service providers, including logistics, compliance support, inspection, and documentation service firms, are affected because importers must provide module source compliance declarations. This increases the need for document consistency across purchase records, shipping files, supplier declarations, and OEM audit packages.

The business impact may appear in pre-shipment checks, document review workflows, traceability file management, and exception handling when the module source is unclear. Service providers may need to prepare for more detailed customer requests related to trade compliance and supply chain evidence.

Practical Points for Companies to Review Now

Confirm whether modules fall within the restricted scope

Companies involved in Photon-counting CT components should first determine whether the image reconstruction modules they export, import, purchase, integrate, or resell match the type of modules referenced in the final determination. This review should remain tied to the information in Investigation No. 337-TA-1428 and patent US11229345B2 rather than broad assumptions about all CT equipment.

Strengthen module source declarations and audit files

Because the determination requires importers to provide a compliance declaration on module source, businesses should ensure that supplier declarations, purchase records, technical descriptions, and shipment documents are aligned. OEM system manufacturers may also need clearer evidence trails when auditing suppliers for U.S.-bound projects.

Align technical specifications with customer and tender requirements

For projects involving OEM supply, technical specifications and procurement documents may need to distinguish complete systems from the affected modules. Companies should review whether bid documents, customer specifications, and acceptance criteria require additional statements about module origin, patent risk screening, or compliance with the ITC final determination.

Reassess delivery schedules for U.S.-related orders

Exporters, importers, and OEM manufacturers may need to reassess delivery timing when compliance declarations or source verification are required before shipment. Any uncertainty around module origin could affect order confirmation, customs preparation, delivery planning, and after-sales traceability for the U.S. market.

Industry Observation: Patent-Based Trade Controls Are Moving Upstream

From an industry perspective, this event illustrates how patent-related trade remedies can affect not only the named module suppliers but also OEM audit practices and upstream sourcing decisions. The confirmed measure is limited to the relevant modules, yet the compliance burden may be felt by companies that assemble or trade complete systems because importers must still verify module source.

Analysis shows that supply chain transparency is becoming more important for high-value medical imaging technologies. It is more appropriate to understand this event as a targeted exclusion affecting specific image reconstruction modules rather than a blanket restriction on all Photon-counting CT systems.

What deserves closer attention is whether future procurement documents, supplier qualification procedures, and technical compliance files place greater emphasis on patent clearance, component traceability, and declaration consistency. These are analytical observations, not confirmed outcomes.

Measured Conclusion for Market Participants

The ITC final determination creates a clear compliance requirement for certain Photon-counting CT image reconstruction modules linked to the U.S. market. While complete systems are not covered by the exclusion, OEM manufacturers, importers, exporters, and supply chain service providers may still need to adjust audit procedures and documentation controls.

The industry significance lies in the connection between intellectual property enforcement and cross-border medical imaging supply chains. Companies should respond with careful scope review, traceable sourcing records, and disciplined communication with customers and suppliers, without overstating the impact beyond the modules identified in the determination.

Information Basis and Items to Monitor

This article is based on the user-provided news title, event date, and event summary concerning the ITC final determination dated June 2, 2026, in Investigation No. 337-TA-1428.

Relevant official or authoritative source types for continued verification may include ITC determination materials, patent records, import compliance guidance, customs documentation requirements, OEM supplier audit instructions, and procurement or tender documents. Specific official source links were not provided in the input and should be verified continuously.

Further monitoring should focus on implementation details, certification and compliance review practices, changes in tender or procurement language, importer declaration requirements, OEM audit expectations, and industry feedback on affected supply chain processes.